Insight

Michael Klichinsky: Carisma Therapeutics received FDA Fast Track Designation for CT-0525

A collage of Michael Klichinsk and Carisma Therapeutics

Jun 27, 2024, 12:32

Michael Klichinsky: Carisma Therapeutics received FDA Fast Track Designation for CT-0525

Michael Klichinsky, Co-Founder and Chief Scientific Officer at Carisma Therapeutics, shared on LinkedIn:

“We are excited to share that Carisma Therapeutics received FDA Fast Track Designation for CT-0525 for the treatment of advanced HER2-overexpressing solid tumors.

More information here.”

Source: Michael Klichinsky/LinkedIn

cancer Carisma Therapeutics CT-0525 FDA HER2 Michael Klichinsky OncoDaily Oncology solid tumors

NEW PAPER ALERT: Efficacy of CDK4/6 Inhibitors and Endocrine Therapy in HR+/HER2- Advanced Breast Cancer by PAM50 Subtype: SOLTI-1801 CDK-PREDICT Results

Oncologist Near Me – Fabrice André: Leading Expert in Breast Cancer

Funding Impactful Cancer Research That Might Otherwise Go Unsupported: Ryan Schoenfeld on the Secret Behind Mark Foundation’s Success

One Hand Gives, Another Takes? Trump, Musk, Congress and Childhood Cancer Research Funding

Fabrice André has been elected as the President of the ESMO for the term 2025-2026

Special Coverage

ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023

Facebook

RSS Feed

Youtube

Blog

Jan 15, 2025, 11:08

Why Dana-Farber Direct Connect? - Dana-Farber Cancer Institute

Blog

Jan 15, 2025, 10:56

Sachin H. Jain: The path forward for the US Health Insurance Industry begins with saying “We Are Sorry”

Blog

Jan 15, 2025, 08:23

Pashtoon Kasi: Different kind of liquid biopsies in guiding care of patients with cancer

Blog

Jan 15, 2025, 08:14

Chokri Ben Lamine: Immune Targets in Hematologic Malignancies

Blog

Jan 15, 2025, 08:06

Shushan Hovsepyan: 20 million participants at the first-ever 2025 CACA-OncoDaily-SPCC Cancer Summit

Opinion

Jan 15, 2025, 07:58

The Power of Equity: Funding Research to Close Gaps in Colorectal Cancer Outcomes

Blog

Jan 15, 2025, 07:53

Moses Echodu: Recounting 2024 and Looking at 2025 - Growth and Acceleration

Blog

Jan 15, 2025, 07:49

Breaking Ground in Genomics: India Launches "Genome India" Database - Canary Oncoceutics

Science

Jan 15, 2025, 07:40

Anirban Maitra: The impact of KRAS allelic status on outcomes in Pancreatic Cancer

Science

Jan 15, 2025, 07:31

Melvin LK Chua: Chromatin-related adaptation for acquired Radioresistance in Head and Neck Cancer

Blog

Jan 15, 2025, 07:27

Akhil Santhosh: I am among the recipients of the ASCO IDEA award 2025

Societies

Jan 15, 2025, 07:22

Benjamin Ebert: Excited to launch the Center for RAS Therapeutics